This may be due to neurite-protective supernatants from benign MS cases containing a higher level of LIF, transforming growth factor (TGF)-β, and brain-derived neurotrophic factor (BDNF) that are classical neurotrophic factors induced by sustained activation of the JAK/STAT signaling (46). The gene discussed is BDNF; the disease is myeloid sarcoma.